Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8

20174 citationsJournal Articlebronze Open Access

Authors

BIL has a markedly lower risk of hypoglycemia than GL when replicating a double-dose error in patients with T2D.

Good health and well-being

Published in: Diabetes Technology & Therapeutics

Volume 19, Issue 8, pp. 463-470

Field-Weighted Citation Impact: 0.18